• Personal Stories

Looking back at a life-changing clinical trial

In an unusual turn of events, the results of a clinical trial for mitoxantrone turned out to be so effective that the randomisation of the trial was halted early.  In an unusual turn of events, the results of a clinical trial for mitoxantrone turned out to be so effective that the randomisation of the trial was halted early. 

16 September 2022

• Health & Medicine

NICE doesn’t recommend olaparib for patients with certain prostate cancers

NICE does not recommend olaparib (Lynparza) for people with a type of advanced prostate cancer, as the treatment is not deemed cost-effective NICE does not recommend olaparib (Lynparza) for people with a type of advanced prostate cancer, as the treatment is not deemed cost-effective

13 September 2022

• Health & Medicine

Help seeking: Why isn’t it as simple as it might sound?

A poll has revealed 50% of UK adults with a possible cancer symptom wait 6 months or more before contacting their GP. Why might people not seek help when they need it? A poll has revealed 50% of UK adults with a possible cancer symptom wait 6 months or more before contacting their GP. Why might people not seek help when they need it?

10 August 2022

• Health & Medicine

Closing the gap: How new screening interventions could reduce inequalities in bowel cancer outcomes

If we can find interventions that help to increase participation in screening programmes amongst lower income groups, we may be able to reduce the health inequalities that exist in bowel cancer outcomes.   If we can find interventions that help to increase participation in screening programmes amongst lower income groups, we may be able to reduce the health inequalities that exist in bowel cancer outcomes.  

5 July 2022

• For Researchers

Government update on the Clinical Research Vision: More needed to go beyond recovery?

Is the Government's implementation plan for its 10-year clinical research vision any more than just rhetoric? Our policy team give us the low-down... Is the Government's implementation plan for its 10-year clinical research vision any more than just rhetoric? Our policy team give us the low-down...

30 June 2022

• Science & Technology
• Health & Medicine

How erectile dysfunction drugs could be the key to overcoming treatment resistance in oesophageal cancer

Researchers have found a drug that targets the tumour microenvironment that could improve treatment for certain cancers. But it might not be the kind of drug you expect.  Researchers have found a drug that targets the tumour microenvironment that could improve treatment for certain cancers. But it might not be the kind of drug you expect. 

21 June 2022

• Science & Technology

Picking out the patterns: How scientists are finding cancer’s signatures in tumour DNA

An international team of researchers have identified 21 common faults in cancer DNA using an algorithm that works similarly to Netflix An international team of researchers have identified 21 common faults in cancer DNA using an algorithm that works similarly to Netflix

15 June 2022

• Health & Medicine

New study supports extending cervical screening intervals for people who test negative for HPV

A new study confirms that offering cervical screening using HPV testing effectively prevents cervical cancer without the need for as regular screening A new study confirms that offering cervical screening using HPV testing effectively prevents cervical cancer without the need for as regular screening

1 June 2022

• Health & Medicine

Cannabis, cannabinoids and cancer – the evidence so far

The current consensus is that, right now, there isn’t a large enough body of evidence to prove that cannabis (or any of its active compounds or derivatives) can reliably treat any form of cancer but the medical use of cannabis to treat cancer-related chronic pain is approved in the UK. The current consensus is that, right now, there isn’t a large enough body of evidence to prove that cannabis (or any of its active compounds or derivatives) can reliably treat any form of cancer but the medical use of cannabis to treat cancer-related chronic pain is approved in the UK.

13 May 2022

• Health & Medicine

Immune cell count could determine whether chemotherapy is required in oropharyngeal cancer, new study finds 

A new study has found that the level of a person's immune cells may provide an indication of whether they would benefit from chemotherapy in oropharyngeal cancer. A new study has found that the level of a person's immune cells may provide an indication of whether they would benefit from chemotherapy in oropharyngeal cancer.

2 May 2022